Mar 07, 2023 / 04:00PM GMT
Jayson Tyler Bedford - Raymond James & Associates, Inc., Research Division - MD & Senior Medical Supplies and Devices Analyst
Good morning and welcome to the 44th annual Raymond James Institutional Investors Conference. I'm Jayson Bedford. I cover the MedTech sector here at RayJay. And it's really a privilege to have with us Masimo. With us, we have Eli Kammerman, VP of IR. Mike is on some sort of secret mission, right? Eli? So with that, I'm going to pass it off to Eli. Thank you.
Eli Kammerman - Masimo Corporation - VP of Business Development & IR
Thanks, Jayson, and thanks to Raymond James for inviting us to present here today. I'm going to start out, as you see me. Unfortunately, I had a small mishap with my regular glasses on the way out here. So for my presentation, so I can see my slides, I'm going to be wearing these sunglasses, which, in fact, are prescription glasses. So please forgive the lack of eye contact. All right.
Okay. First, take note of our safe harbor statement regarding forward-looking statements as well as non-GAAP
Masimo Corp at Raymond James Institutional Investors Conference Transcript
Mar 07, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers